Europe Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), End User (Hos

Europe Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)

The Europe intradermal injections market is expected to reach US$ 2,131.1 million by 2028 from US$ 1,029.4 million in 2021; it is estimated to grow at a CAGR of 11.0% from 2021 to 2028. Recently, rapid increase in the aesthetic procedures is observed at Europe. Many leading aesthetic procedures involve the use of intradermal injections. Neurotoxins-related aesthetic procedures are the leading one. Intradermal injections are mainly used for delivering various neurotoxins, which ultimately increases the demand for intradermal injections. Further, developing countries are also adopting the cosmetic surgeries, which would act as major driver for the growth of the market during the forecast period.

Based on method, the intradermal injections market is segmented into normal-sized needles, short needles, and without needles. In 2020, the normal-sized needles segment accounted for the largest share, short needles segment is expected to grow at the highest CAGR in the forecast period.

The rising number of COVID-19 cases increased stress on the healthcare system of Europe, raising the demand for diagnostic tests, supporting the expansion of the sector in the region. The increasing cases propelled the need for essential medicines, which ultimately bolstered the demand for drug delivery devices including the intradermal injections. Recently, an intradermal vaccine of Pfizer got approval in Europe for the management of COVID-19. The intradermal injection market witnessed some shortfall at the beginning of the COVID-19 crisis due to factors such as disruption in supply chain and demand due to lockdown announced by most European countries. Market players and end-users experienced losses in their business due to the temporarily shutdown of industries in various countries.

The overall Europe intradermal injections market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast for the Europe intradermal injections market with respect to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. Participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the Europe intradermal injections market. Companies adopt a few strategies, such as mergers and acquisitions and market initiatives, which promotes market growth. BD, West Pharmaceutical Services, Inc., Terumo Corporation, NanoPass, Pharmajet, Idevax, EUNSUNG GLOBAL, Crossject, Cardinal Health Inc., and Hindustan Syringes and Medical Devices Ltd are among the major players operating in the market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific intradermal injections market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.